tirzepatide and mash fda Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH Tirzepatide in metabolic dysfunction-associated steatotic

TRIUMPH-1 included an overarching trial for adults with obesity and two nested basket trials, one of which focused on moderate-to-severe OSA

Some hormonal IUDs can cause changes in your period, such as lighter bleeding or no bleeding at all

Cardiovascular benefits: May reduce the risk of major adverse cardiovascular events (MACE)

The clear separation between treatment and placebo groups (5272 vs 9.6 hairs) leaves little room for doubt about efficacy

Nutritional deficiencies particularly protein, iron, and zinc can contribute to hair shedding during caloric restriction and should be assessed clinically

Semaglutide, found in Ozempic and Wegovy, acts solely through GLP-1, while tirzepatide in Mounjaro affects both GLP-1 and GIP